Clinical Trial Update: Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of an allogeneic tumor cell vaccine in patients with metastatic solid tumors was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Allogeneic tumor cell vaccine (allogeneic tumor cell vaccine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Solid Tumors | Phase 1, Phase 2 | Status: WITHDRAWN